Cite
HARVARD Citation
Zhong, J. et al. (2019). ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy. Thoracic cancer. 10 (11), pp. 2088-2095. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhong, J. et al. (2019). ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy. Thoracic cancer. 10 (11), pp. 2088-2095. [Online].